Unlocking Advanced Breast Cancer Treatment with 4-(2-acetamidoethyl)-Benzaldehyde
Discover the pivotal role of this key intermediate in pioneering cancer therapies.
Get a Quote & SampleProduct Core Value
4-(2-acetamidoethyl)-Benzaldehyde
This chemical compound, identified by CAS No. 61629-92-3, is a critical building block in the pharmaceutical industry, specifically for the synthesis of Elacestrant, a groundbreaking oral selective estrogen receptor degrader (SERD). Elacestrant has shown significant promise in treating patients with ER-positive, HER2-negative advanced or metastatic breast cancer, particularly those with ESR1 mutations. The development and availability of intermediates like 4-(2-acetamidoethyl)-Benzaldehyde are essential for advancing cancer treatment research and providing effective therapeutic options.
- The synthesis of Elacestrant relies heavily on high-purity 4-(2-acetamidoethyl)-Benzaldehyde, directly impacting its efficacy in treating advanced breast cancer.
- As a pharmaceutical intermediate, this chemical plays a vital role in advancing the development of targeted therapies for hormone receptor-positive breast cancer patients.
- Understanding the role of this chemical for Elacestrant synthesis is crucial for researchers and manufacturers in the oncology sector.
- The availability of reliable suppliers for this 4-(2-acetamidoethyl)-Benzaldehyde intermediate is key to ensuring consistent production of vital cancer medications.
Advantages This Product Brings
Enabling Targeted Therapies
This chemical intermediate is fundamental for producing Elacestrant, offering a new avenue for patients with ESR1-mutated breast cancer, thereby improving treatment outcomes.
Facilitating Drug Development
Its role as a key component in Elacestrant synthesis accelerates the drug development pipeline for novel cancer treatments, supporting the fight against this disease.
Ensuring Quality and Purity
High standards in the production of this 4-(2-acetamidoethyl)-Benzaldehyde chemical for Elacestrant synthesis guarantee the safety and effectiveness of the final API.
Key Applications
Pharmaceutical Synthesis
Serving as a crucial building block for active pharmaceutical ingredients (APIs), especially Elacestrant, a vital drug for breast cancer treatment.
Oncology Research
Essential for developing and manufacturing targeted therapies for hormone receptor-positive and ESR1-mutated breast cancer, advancing medical research.
Custom Synthesis Projects
A valuable compound for custom synthesis services, enabling the creation of specialized molecules for various research and development needs.
API Manufacturing
Critical for the commercial production of Elacestrant, contributing to the global supply chain of advanced cancer therapeutics.